I. Kikuchi et al., THE EFFECT OF HLA ALLELES ON RESPONSE TO INTERFERON THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C, European journal of gastroenterology & hepatology, 10(10), 1998, pp. 859-863
Objective To compare HLA alleles in the patients with chronic hepatiti
s C treated with interferon-alpha (IFN-alpha) between patients with re
sponse to IFN treatment and nonresponse. Method Sixty-seven Japanese p
atients with chronic hepatitis C were treated with daily intramuscular
administration of IFN-alpha (6 million units) for 2 weeks followed by
three times per week for 22 weeks, Viral loads of hepatitis virus C (
HCV), HCV genotypes and HLA antigens were determined just before IFN-a
lpha treatment, Responders to IFN-alpha were defined as normalization
of alanine aminotransferase at the end of treatment and during a follo
w-up period at least longer than 6 months, The patients who could not
reach the above response criteria were defined as nonresponders. Resul
ts There were 20 responders and 47 nonresponders to IFN treatment, The
low viral load with less than 1 x 10(6) copy/ml (P < 0.05), and type
2a genotype (P < 0.05) were significantly increased in responders, Oth
er clinical and biochemical parameters were not significant. There was
no difference in HLA-A and C antigens between responders and nonrespo
nders. In contrast, HLA-B54,DR4 and A24-B54-DR4 haplotype of nonrespon
ders increased compared with responders or controls (P-c < 0.0001, P-c
< 0.001, P-c < 0.0001, respectively), At multivariate analysis, viral
loads, HLA-B54 and HLA-A24-B54-DR4 haplotype were significant (P = 0.
0002, P = 0.0258, P = 0.0378, respectively), Conclusion The low viral
load is a good predictor. HLA-B54 and HLA-A24-B54-DR4 haplotype should
be predictors for poor response to IFN therapy in patients with chron
ic hepatitis C, fur J Gastroenterol Hepatol 10:859-863 (C) 1998 Lippin
cott Williams & Wilkins.